A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer

PURPOSE: The current multicenter phase II study was conducted to evaluate the efficacy and safety of the combination of docetaxel and gemcitabine as neoadjuvant chemotherapy (NAC) for locally advanced breast cancer. METHODS: A total of 98 patients with stage II–III breast cancer were enrolled. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Ye Won, Kim, Tae Hyun, Youn, Hyun Jo, Han, Sehwan, Jung, Yongsik, Gwak, Geumhee, Park, Young Sam, Kim, Jeong Soo, Suh, Young Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743993/
https://www.ncbi.nlm.nih.gov/pubmed/29285038
http://dx.doi.org/10.4048/jbc.2017.20.4.340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743993/
https://www.ncbi.nlm.nih.gov/pubmed/29285038
http://dx.doi.org/10.4048/jbc.2017.20.4.340

Ejemplares similares